178 related articles for article (PubMed ID: 22971456)
1. Serum albumin levels in women with ovarian hyperstimulation syndrome with or without polycystic ovaries.
Alserri A; Holzer H; Tulandi T
J Obstet Gynaecol Can; 2012 Sep; 34(9):866-869. PubMed ID: 22971456
[TBL] [Abstract][Full Text] [Related]
2. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.
Agrawal R; Conway G; Sladkevicius P; Tan SL; Engmann L; Payne N; Bekir J; Campbell S; Jacobs H
Fertil Steril; 1998 Oct; 70(4):651-8. PubMed ID: 9797093
[TBL] [Abstract][Full Text] [Related]
3. [A relation between the polycystic ovary syndrome and the status of ovarian hyperstimulation syndrome in IVF patients after controlled hyperstimulation].
Moosová M; Moos J; Filová V; Pavelková J; Jarosová R; Rezábek K
Ceska Gynekol; 2011 Apr; 76(2):123-7. PubMed ID: 21649996
[TBL] [Abstract][Full Text] [Related]
4. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
Manzanares MA; Gómez-Palomares JL; Ricciarelli E; Hernández ER
Fertil Steril; 2010 Mar; 93(4):1215-9. PubMed ID: 19200978
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the clinical outcomes of IVF-ET treatment in infertile patients with polycystic ovary syndrome or polycystic ovaries].
Wang QL; Song J; Chen SL; Luo C; Chen X; Li M; Ni YP
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):962-5. PubMed ID: 19460721
[TBL] [Abstract][Full Text] [Related]
6. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
7. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
8. IVF outcome in women with PCOS, PCO and normal ovarian morphology.
Swanton A; Story L; McVeigh E; Child T
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):68-71. PubMed ID: 20022685
[TBL] [Abstract][Full Text] [Related]
9. Severe ovarian hyperstimulation syndrome (OHSS) and icterus.
Nawroth F; Heinrich J; Bruns U; Wood WG
Hum Reprod; 1996 Nov; 11(11):2441-2. PubMed ID: 8981129
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization.
Enskog A; Henriksson M; Unander M; Nilsson L; Brännström M
Fertil Steril; 1999 May; 71(5):808-14. PubMed ID: 10231037
[TBL] [Abstract][Full Text] [Related]
11. Persistent megalocystic ovary following in vitro fertilization in a postpartum patient with polycystic ovarian syndrome.
Ling SY; Chong KM; Hwang JL
Taiwan J Obstet Gynecol; 2006 Mar; 45(1):70-2. PubMed ID: 17272214
[TBL] [Abstract][Full Text] [Related]
12. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
Zhu WJ; Li XM; Chen XM; Zhang L
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
[TBL] [Abstract][Full Text] [Related]
13. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
[TBL] [Abstract][Full Text] [Related]
14. Two cases of polycystic ovary syndrome with onset of severe ovarian hyperstimulation syndrome following controlled ovarian stimulation with aromatase inhibitors for fertility preservation before breast cancer treatment.
Oishi S; Mekaru K; Nakamura R; Miyagi M; Akamine K; Heshiki C; Aoki Y
Taiwan J Obstet Gynecol; 2021 Sep; 60(5):931-934. PubMed ID: 34507678
[TBL] [Abstract][Full Text] [Related]
15. Total ovarian volume before human chorionic gonadotrophin administration for ovulation induction may predict the hyperstimulation syndrome.
Oyesanya OA; Parsons JH; Collins WP; Campbell S
Hum Reprod; 1995 Dec; 10(12):3211-12. PubMed ID: 8822446
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
[TBL] [Abstract][Full Text] [Related]
17. Role of serum miRNAs in the prediction of ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients.
Zhao C; Liu X; Shi Z; Zhang J; Zhang J; Jia X; Ling X
Cell Physiol Biochem; 2015; 35(3):1086-94. PubMed ID: 25662703
[TBL] [Abstract][Full Text] [Related]
18. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.
MacDougall MJ; Tan SL; Balen A; Jacobs HS
Hum Reprod; 1993 Feb; 8(2):233-7. PubMed ID: 8473426
[TBL] [Abstract][Full Text] [Related]
19. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
Das M; Son WY; Buckett W; Tulandi T; Holzer H
Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
[TBL] [Abstract][Full Text] [Related]
20. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]